COPENHAGEN, Denmark, May 29, 2012 (GLOBE NEWSWIRE) -- Zealand Pharma A/S (Copenhagen:ZEAL), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, today announces that the company will present at the following upcoming healthcare investor conferences:
